Literature DB >> 8747000

Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.

B D Wilson1, M L Lippmann.   

Abstract

In previous studies, we showed that Fischer rats fed 175 mg/kg of amiodarone accumulated large amounts of drug and metabolite in the lung and developed pulmonary toxicity, whereas Wistar rats fed the same drug dose had significantly less amiodarone in the lung and did not develop pulmonary inflammation. The present study was designed to determine whether this difference in susceptibility between the strains was related to differences in uptake of amiodarone by lung cells. We found that isolated mixed lung cells of Fischer rats sequester significantly more drug than cells from Wistar rats. This difference in uptake cannot be due to drug metabolism because the lung is not capable of metabolizing amiodarone. We also found that the alveolar macrophage is one of the cell types in the mixed cell population that is partially responsible for the difference in drug uptake and that fibroblasts and type II pneumocytes are not involved. In addition, despite the fact that there was no difference in drug uptake, we found that fibroblasts isolated from Fischer rats were more susceptible to amiodarone-induced cytotoxicity than were Wistar fibroblasts. We conclude that genetic differences in lung drug sequestration and possibly the sensitivity to cytotoxicity may explain differences in susceptibility to amiodarone-induced pulmonary toxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8747000     DOI: 10.1007/bf00167949

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  24 in total

1.  Pleural T-lymphocyte subsets in amiodarone-associated pleuropneumonitis.

Authors:  G M Akoun; B J Milleron; D M Badaro; C M Mayaud; H A Liote
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

2.  Augmentation of fibroblast proliferation by bleomycin.

Authors:  P L Moseley; C Hemken; G W Hunninghake
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 3.  Lipidosis induced by amphiphilic cationic drugs.

Authors:  H Lüllmann; R Lüllmann-Rauch; O Wassermann
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

Review 4.  Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.

Authors:  F I Marcus; G H Fontaine; R Frank; Y Grosgogeat
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

5.  Amiodarone-induced pulmonary toxicity in the rat.

Authors:  B D Wilson; A J Jaworski; M E Donner; M L Lippmann
Journal:  Lung       Date:  1989       Impact factor: 2.584

6.  Leukocyte migration inhibition in amiodarone-associated pneumonitis.

Authors:  G M Akoun; S Gauthier-Rahman; H A Liote; B J Milleron; C M Mayaud
Journal:  Chest       Date:  1988-11       Impact factor: 9.410

7.  Bronchoalveolar lavage in amiodarone pneumonitis. Cellular abnormalities and their relevance to pathogenesis.

Authors:  D Israël-Biet; A Venet; I Caubarrère; G Bonan; C Danel; J Chrétien; A J Hance
Journal:  Chest       Date:  1987-02       Impact factor: 9.410

8.  Anti-amiodarone antibodies: detection and relationship to the development of side effects.

Authors:  W J Pichler; L Schindler; M Stäubli; B M Stadler; A L de Weck
Journal:  Am J Med       Date:  1988-08       Impact factor: 4.965

9.  Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.

Authors:  W J Martin; D M Howard
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

10.  Pulmonary sequestration of amiodarone and desethylamiodarone.

Authors:  P Camus; H M Mehendale
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.